Saturday, October 12, 2024 12:38:16 PM
Look at the years 1981 through 1985, there were many days where Apple's pps opened and/or closed under $1. Your statement actually proves my point: The PPS at a given point in time cannot be the sole variable one looks at in examining the investment value of a company. Thank you. You rightly included stock splits and multiplier. It is appropriate to state those facts. But Mr. moderator, why won't you comment on the variables naysayers intentionally ignore with this same vigor? Your vigor is misplaced. Does it reveal you true stance on NWBO?
Funny how NWBO naysayers harp solely on the .30 pps of a pre-market company but absolutely ignore the efficacy of DCVax (the ONLY real treatment for all tumor-based cancers), automated/infinitely scalable manufacturing, protective patents, and demand that will be insatiable, once DCVax is approved. Some of these naysayers will actually (and foolishly) deny these points.
Funny how NWBO naysayers harp solely on the .30 pps of a pre-market company but absolutely ignore the efficacy of DCVax (the ONLY real treatment for all tumor-based cancers), automated/infinitely scalable manufacturing, protective patents, and demand that will be insatiable, once DCVax is approved. Some of these naysayers will actually (and foolishly) deny these points.
“When bad men combine, the good must associate; else they will fall one by one, an unpitied sacrifice in a contemptible struggle.”
~Edmund Burke
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
